Powerlifter suspended for anti-doping rule violation
The Sports Tribunal has suspended powerlifter Jason Anderson for two years after testing positive for tamoxifen. Mr Anderson’s suspension is backdated to 13 May 2019 – the date of Mr Anderson’s sample collection.
Mr Anderson was tested out of competition as a result of credible information received from a concerned member of the powerlifting community.
DFSNZ Chief Executive Nick Paterson says: “We want to acknowledge the person who brought this information to our attention. No matter how minor the information may seem to the person making the report, clean athletes should know that concerned members of the sporting community can and do “Speak Out” confidentially. DFSNZ will consider every piece of information received and act on it if appropriate.
“Mr Anderson has said his use of tamoxifen was medical and not for performance enhancing reasons. However, tamoxifen is on WADA’s Prohibited List as it is commonly used to counter the negative side effects of anabolic steroids. To protect clean sport, all athletes need to stay clear of all prohibited substances.”
Tamoxifen is a prescription-only medicine in the class of hormone and metabolic modulators and is commonly used to treat breast cancer.
New Zealand Olympic Committee: Motherhood In Focus For Wāhine Toa Graduates Ahead Of Mother's Day
Early Childhood New Zealand: Budget 2026 Must Protect The Future Of Quality Early Childhood Education
Creative New Zealand: Aotearoa Manu Take World Art Stage As 61st Venice Biennale Opens
Country Music Honours: 2026 Country Music Honours Finalists Announced
Mana Mokopuna: Children’s Commissioner Welcomes New Youth Mental Health And Suicide Prevention Services In Te Tai Tokerau
New Zealand Kindergartens: 100-Years On - Investing In Teacher-Led, Quality Early Childhood Education Is Investing In Aotearoa’s Future